tiprankstipranks
Trending News
More News >
Hoya Corp (HOCPY)
:HOCPY
Advertisement

HOYA (HOCPY) AI Stock Analysis

Compare
31 Followers

Top Page

HO

HOYA

(OTC:HOCPY)

Rating:72Outperform
Price Target:
$130.00
▲(4.60%Upside)
HOYA's strong financial performance is the primary driver of its overall stock score, reflecting robust profitability, minimal leverage, and effective cash flow management. The technical analysis suggests limited momentum, with the stock trading below key moving averages, impacting its attractiveness. The valuation indicates the stock is relatively expensive, which may be a deterrent for value-focused investors. The absence of new earnings call data and corporate events means these factors do not influence the score.

HOYA (HOCPY) vs. SPDR S&P 500 ETF (SPY)

HOYA Business Overview & Revenue Model

Company DescriptionHOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHOYA makes money through a diverse range of revenue streams that span its two primary segments: Life Care and Information Technology. In the Life Care segment, the company generates revenue from the sale of eyeglass lenses, contact lenses, and medical endoscopes, which are distributed globally through various retail partners and healthcare providers. In the Information Technology segment, HOYA earns income from the production and sale of photomasks and mask blanks, which are critical components in the semiconductor manufacturing process, as well as glass substrates used in hard disk drives. The company benefits from strategic partnerships and a strong global distribution network, which enhance its ability to reach customers and drive sales across different markets.

HOYA Financial Statement Overview

Summary
HOYA exhibits strong financial health across all verticals, driven by effective revenue growth, robust profitability, minimal leverage, and solid cash flow generation. The company's financial position is fortified by high equity levels and substantial cash reserves, positioning it well for sustained growth and resilience against economic challenges. Despite minor fluctuations in growth rates and cash flow metrics, the overall financial trajectory remains positive and stable.
Income Statement
85
Very Positive
HOYA demonstrates strong profitability with robust gross profit and net profit margins across the years. The company has shown consistent revenue growth, achieving an impressive revenue growth rate from 2024 to 2025, indicating solid market demand and operational efficiency. The EBIT and EBITDA margins are also healthy, reflecting effective cost management. However, the growth rate between 2020 and 2021 was less pronounced, suggesting some variability in revenue expansion.
Balance Sheet
90
Very Positive
HOYA's balance sheet is notably strong, characterized by a high equity ratio indicating substantial shareholder funding compared to total assets. The debt-to-equity ratio is low, highlighting minimal leverage and reduced financial risk. Return on equity is strong, showcasing effective management in generating returns from shareholder investment. The company's substantial cash reserves further enhance financial stability.
Cash Flow
80
Positive
The cash flow statement reflects a positive trajectory, with consistent free cash flow generation supporting the company's growth initiatives. The operating cash flow to net income ratio is favorable, indicating efficient conversion of earnings into cash. Although the free cash flow growth rate varies across years, the overall trend is upward, suggesting prudent capital expenditure management. A minor point of concern is the fluctuation in investing cash flow, which could impact future profitability.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue885.82B762.61B734.10B670.33B558.26B
Gross Profit766.25B421.69B631.86B567.28B474.98B
EBITDA310.00B285.70B259.78B243.96B200.27B
Net Income202.10B181.38B168.64B164.51B125.45B
Balance Sheet
Total Assets1.23T1.20T1.03T992.84B853.29B
Cash, Cash Equivalents and Short-Term Investments538.53B525.16B426.27B426.63B338.79B
Total Debt37.28B29.24B24.58B21.60B20.75B
Total Liabilities262.65B241.36B213.72B203.78B180.88B
Stockholders Equity974.02B967.76B818.32B803.85B688.00B
Cash Flow
Free Cash Flow187.19B181.73B168.36B161.18B120.57B
Operating Cash Flow235.11B222.80B201.83B190.06B151.81B
Investing Cash Flow-33.19B-35.81B-47.50B-29.30B-29.79B
Financing Cash Flow-190.35B-110.89B-194.59B-106.72B-115.67B

HOYA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price124.28
Price Trends
50DMA
119.33
Positive
100DMA
117.09
Positive
200DMA
124.24
Positive
Market Momentum
MACD
1.60
Negative
RSI
62.13
Neutral
STOCH
99.72
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Positive. The current price of 124.28 is above the 20-day moving average (MA) of 119.06, above the 50-day MA of 119.33, and above the 200-day MA of 124.24, indicating a bullish trend. The MACD of 1.60 indicates Negative momentum. The RSI at 62.13 is Neutral, neither overbought nor oversold. The STOCH value of 99.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HOCPY.

HOYA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
RMRMD
83
Outperform
$37.82B28.9625.81%0.81%9.54%37.23%
72
Outperform
$42.50B32.3520.56%<0.01%7.74%7.29%
COCOO
69
Neutral
$14.49B34.595.15%6.88%21.11%
WSWST
64
Neutral
$15.15B33.1217.42%0.40%-1.14%-16.35%
64
Neutral
$4.91B-5.56%11.94%-6.98%
52
Neutral
$7.37B-0.04-63.81%2.59%16.40%<0.01%
51
Neutral
$859.77M55.81-19.14%-14.44%-557.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HOCPY
HOYA
124.28
5.75
4.85%
COO
Cooper Co
71.32
-19.35
-21.34%
RMD
Resmed
261.07
53.41
25.72%
STAA
Staar Surgical
17.76
-24.11
-57.58%
WST
West Pharmaceutical Services
210.08
-105.18
-33.36%
BLCO
Bausch + Lomb Corporation
13.93
-3.10
-18.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025